Literature DB >> 32409849

Comprehensive profiling of circRNAs and the tumor suppressor function of circHIPK3 in clear cell renal carcinoma.

Haomin Li1, Baoli Heng2,3, Peng Ouyang1, Xuexia Xie1, Tingshun Zhang1, Guo Chen1, Zheng Chen1, Kahong Cheang4, Caiyong Lai5,6.   

Abstract

Increasing evidence has indicated that circular RNAs (circRNAs) play a key role in the development and progression of diverse cancers, but their role in clear cell renal carcinoma (CCRCC) tumorigenesis is not well understood. In this study, we firstly performed comprehensive circRNA-seq from CCRCC tissues and pair-matched adjacent normal tissues. In total, 1184 circRNAs were dysregulated in human CCRCC tissues compared with those in adjacent normal tissues. We randomly selected four circRNAs, including circHIPK3 (circBase ID: hsa_circ_0000284), to test the circRNA-seq data in another 40 CCRCC tissues by quantitative real-time PCR (qRT-PCR). Furthermore, we found that circHIPK3 was downregulated in CCRCC tissues and cell lines. Overexpression of circHIPK3 effectively suppressed CCRCC cell invasion and migration in vitro, and inhibited CCRCC cell proliferation in vitro and in vivo. Moreover, bioinformatic analysis and luciferase reporter assay showed that circHIPK3 targeted miR-637 in CCRCC cells. Hence, CircHIPK3 may represent a tumor suppressor and target miR-637 in clear cell renal carcinoma.

Entities:  

Keywords:  CircHIPK3; CircRNA; Circular RNA; Clear cell renal carcinoma; Renal carcinoma; miR-637

Mesh:

Substances:

Year:  2020        PMID: 32409849     DOI: 10.1007/s10735-020-09882-9

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  9 in total

Review 1.  The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinoma.

Authors:  Hui Huang; Tao Chen; Fei Li; Dan Jin; Chuan Li; Yongbo Yang; Xuyang Liu; Dongmiao Wang; Jiehui Di
Journal:  Med Oncol       Date:  2022-05-15       Impact factor: 3.064

Review 2.  Disease-Associated Circular RNAs: From Biology to Computational Identification.

Authors:  Min Tang; Ling Kui; Guanyi Lu; Wenqiang Chen
Journal:  Biomed Res Int       Date:  2020-08-17       Impact factor: 3.411

3.  Emerging landscape of circHIPK3 and its role in cancer and other diseases (Review).

Authors:  Qi Shao; Yong Huang; Cai Zhang; Xiaochan Gao; Shiyang Gao
Journal:  Mol Med Rep       Date:  2021-03-31       Impact factor: 2.952

4.  Hsa_circRNA_0045861 promotes renal injury in ureteropelvic junction obstruction via the microRNA-181d-5p/sirtuin 1 signaling axis.

Authors:  Xu Fan; Xiaoming Yin; Qi Zhao; Yi Yang
Journal:  Ann Transl Med       Date:  2021-10

5.  piRNA-31115 Promotes Cell Proliferation and Invasion via PI3K/AKT Pathway in Clear Cell Renal Carcinoma.

Authors:  Xinghua Du; Haomin Li; Xuexia Xie; Liping Shi; Fan Wu; Guoliang Li; Caiyong Lai; Baoli Heng
Journal:  Dis Markers       Date:  2021-11-08       Impact factor: 3.434

6.  The novel circular RNA HIPK3 accelerates the proliferation and invasion of hepatocellular carcinoma cells by sponging the micro RNA-124 or micro RNA-506/pyruvate dehydrogenase kinase 2 axis.

Authors:  Qiangfeng Yu; Wenxiang Chen; Yiming Li; Jun He; Yu Wang; Sijia Yang; Jianyin Zhou
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

7.  Downregulation of Circular RNA circPSD3 Promotes Metastasis by Modulating FBXW7 Expression in Clear Cell Renal Cell Carcinoma.

Authors:  Xuexia Xie; Haomin Li; Chongqing Gao; Yiqi Lai; Junjie Liang; Zhiwei Chen; Zheng Chen; Baoli Heng; Nan Yao; Caiyong Lai
Journal:  J Oncol       Date:  2022-03-07       Impact factor: 4.375

8.  Using Graph Attention Network and Graph Convolutional Network to Explore Human CircRNA-Disease Associations Based on Multi-Source Data.

Authors:  Guanghui Li; Diancheng Wang; Yuejin Zhang; Cheng Liang; Qiu Xiao; Jiawei Luo
Journal:  Front Genet       Date:  2022-02-07       Impact factor: 4.599

Review 9.  Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis.

Authors:  Jinze Shen; Chenhao Liang; Xinming Su; Qurui Wang; Yufei Ke; Jie Fang; Dayong Zhang; Shiwei Duan
Journal:  Biomark Res       Date:  2022-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.